Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice
- 作者: Kolik L.1, Nadorova A.1, Seredenin S.1
-
隶属关系:
- V. V. Zakusov Research Institute of Pharmacology
- 期: 卷 162, 编号 1 (2016)
- 页面: 56-59
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/237899
- DOI: https://doi.org/10.1007/s10517-016-3544-6
- ID: 237899
如何引用文章
详细
The effect of non-benzodiazepine anxiolytics on the ethanol-induced hyperlocomotion and behavioral sensitization was assessed in male DBA/2 mice. Selank that enhances activity of the endogenous opioid system (0.3 mg/kg, intraperitoneally), similar to the nonselective opiate receptor blocker naloxone (1.0 mg/kg, intraperitoneally), prevented the development of ethanol-induced (2.0 g/kg intraperitoneally) hyperlocomotion, in contrast to σ1-receptors agonist Afobazole (1.0 mg/kg, intraperitoneally) that did not inhibit ethanol-induced behavioral stimulation. Single dose of Selank significantly blocked manifestation of motor sensitization without affecting its formation. These findings suggest that Selank can modulate the motivational effects of ethanol.
作者简介
L. Kolik
V. V. Zakusov Research Institute of Pharmacology
编辑信件的主要联系方式.
Email: lgkolik@mail.ru
俄罗斯联邦, Moscow
A. Nadorova
V. V. Zakusov Research Institute of Pharmacology
Email: lgkolik@mail.ru
俄罗斯联邦, Moscow
S. Seredenin
V. V. Zakusov Research Institute of Pharmacology
Email: lgkolik@mail.ru
俄罗斯联邦, Moscow
![](/img/style/loading.gif)